Kraig Biocraft Laboratories (KBLB) Income from Continuing Operations (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 787621.0 for Q4 2025.

• Income from Continuing Operations for Q4 2025 came in at 787621.0, up 7.52% year-over-year; the trailing twelve-month figure through Dec 2025 was 3623353.0 (down 6.6% YoY), and the FY2025 annual result was 3623353.0, down 6.6% from the prior year.
• Income from Continuing Operations came in at 787621.0 for Q4 2025 at Kraig Biocraft Laboratories, up from 1509566.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 433200.0 in Q3 2024 to a low of 3187147.0 in Q3 2021.
• The 5-year median for Income from Continuing Operations is 896168.5 (2021), against an average of 1096994.45.
• Across the five-year window, Income from Continuing Operations tumbled 384.14% in 2021 and surged 74.57% in 2022, its largest moves.
• Kraig Biocraft Laboratories' Income from Continuing Operations stood at 1164219.0 in 2021, then advanced by 18.67% to 946847.0 in 2022, then plunged by 39.9% to 1324634.0 in 2023, then soared by 35.7% to 851675.0 in 2024, then gained by 7.52% to 787621.0 in 2025.
• The last three Income from Continuing Operations figures came in at 787621.0 (Q4 2025), 1509566.0 (Q3 2025), and 726133.0 (Q2 2025), per Business Quant data.